Lichen International (LICN) Competitors $4.29 -0.05 (-1.15%) Closing price 08/20/2025 03:59 PM EasternExtended Trading$4.47 +0.18 (+4.17%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LICN vs. LDWY, SUGP, WWAC, BIAF, BIYA, DRCT, CDTG, ULY, FTFT, and MSPRShould you be buying Lichen International stock or one of its competitors? The main competitors of Lichen International include Lendway (LDWY), SU Group (SUGP), Worldwide Webb Acquisition (WWAC), bioAffinity Technologies (BIAF), Baiya International Group (BIYA), Direct Digital (DRCT), CDT Environmental Technology Investment (CDTG), Urgent.ly (ULY), Future FinTech Group (FTFT), and MSP Recovery (MSPR). These companies are all part of the "business services" industry. Lichen International vs. Its Competitors Lendway SU Group Worldwide Webb Acquisition bioAffinity Technologies Baiya International Group Direct Digital CDT Environmental Technology Investment Urgent.ly Future FinTech Group MSP Recovery Lendway (NASDAQ:LDWY) and Lichen International (NASDAQ:LICN) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation. Do institutionals & insiders have more ownership in LDWY or LICN? 6.6% of Lendway shares are held by institutional investors. 13.2% of Lendway shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger earnings & valuation, LDWY or LICN? Lendway has higher revenue and earnings than Lichen International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLendway$42.18M0.21-$5.74M-$2.47-2.04Lichen International$41.48M0.06-$6.14MN/AN/A Is LDWY or LICN more profitable? Lichen International has a net margin of 0.00% compared to Lendway's net margin of -10.37%. Lichen International's return on equity of 0.00% beat Lendway's return on equity.Company Net Margins Return on Equity Return on Assets Lendway-10.37% -32.18% -4.54% Lichen International N/A N/A N/A Does the media favor LDWY or LICN? In the previous week, Lendway had 1 more articles in the media than Lichen International. MarketBeat recorded 1 mentions for Lendway and 0 mentions for Lichen International. Lendway's average media sentiment score of 0.50 beat Lichen International's score of 0.00 indicating that Lendway is being referred to more favorably in the media. Company Overall Sentiment Lendway Positive Lichen International Neutral Which has more risk and volatility, LDWY or LICN? Lendway has a beta of 2.49, suggesting that its share price is 149% more volatile than the S&P 500. Comparatively, Lichen International has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. SummaryLendway beats Lichen International on 8 of the 11 factors compared between the two stocks. Get Lichen International News Delivered to You Automatically Sign up to receive the latest news and ratings for LICN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LICN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LICN vs. The Competition Export to ExcelMetricLichen InternationalFIN IndustryFinance SectorNASDAQ ExchangeMarket Cap$2.60M$7.58B$12.34B$9.66BDividend YieldN/A4.81%5.52%4.07%P/E RatioN/A17.0919.0325.05Price / Sales0.066.4725.7986.14Price / CashN/A23.8821.7758.50Price / Book0.034.492.296.15Net Income-$6.14M$311.02M$1.01B$265.47M7 Day Performance-10.63%-4.36%-0.56%-1.51%1 Month Performance-0.46%-4.57%0.48%-1.15%1 Year Performance-98.93%23.72%540.05%18.45% Lichen International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LICNLichen InternationalN/A$4.29-1.2%N/A-98.9%$2.60M$41.48M0.00390LDWYLendway1.1786 of 5 stars$5.01-1.0%N/A+26.8%$8.95M$37.77M-2.0330Short Interest ↓SUGPSU Group1.4785 of 5 stars$0.63-2.1%N/A-67.0%$8.95M$23.43M0.00N/ANews CoverageGap DownWWACWorldwide Webb AcquisitionN/A$0.80-0.7%N/A-62.4%$8.34MN/A0.002,021Gap UpBIAFbioAffinity Technologies0.3649 of 5 stars$0.28-3.1%N/A-85.4%$8.20M$9.36M-0.3910Earnings ReportBIYABaiya International GroupN/A$0.60-7.8%N/AN/A$8.08M$12.81M0.0024Gap DownDRCTDirect Digital2.506 of 5 stars$0.42-2.1%$6.00+1,342.3%-87.9%$8.04M$62.29M-0.2360Short Interest ↑CDTGCDT Environmental Technology InvestmentN/A$0.64+5.5%N/A-82.9%$7.52M$29.76M0.00107Gap UpULYUrgent.ly2.548 of 5 stars$5.04-1.2%$13.50+167.9%-58.2%$7.12M$142.90M-0.16753Analyst RevisionFTFTFuture FinTech Group0.8234 of 5 stars$1.77-6.3%N/A-45.2%$6.52M$2.16M0.0070Earnings ReportMSPRMSP RecoveryN/A$0.69-7.7%N/AN/A$6.15M$18.25M0.003Earnings Report Related Companies and Tools Related Companies LDWY Alternatives SUGP Alternatives WWAC Alternatives BIAF Alternatives BIYA Alternatives DRCT Alternatives CDTG Alternatives ULY Alternatives FTFT Alternatives MSPR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LICN) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lichen International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lichen International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access